行情

AMPH

AMPH

Amphastar Pharms
NASDAQ

实时行情|Nasdaq Last Sale

19.89
-0.43
-2.12%
盘后: 19.89 0 0.00% 16:10 08/11 EDT
开盘
20.32
昨收
20.32
最高
20.60
最低
19.81
成交量
28.31万
成交额
--
52周最高
22.85
52周最低
12.33
市值
9.19亿
市盈率(TTM)
19.05
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测AMPH价格均价为22.40,最高价位24.00,最低价为20.00。

EPS

AMPH 新闻

更多
Amphastar Pharmaceuticals' (AMPH) Management on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 3天前
Amphastar Pharmaceuticals EPS beats by $0.02, misses on revenue
Amphastar Pharmaceuticals (NASDAQ:AMPH): Q2 Non-GAAP EPS of $0.16 beats by $0.02; GAAP EPS of $0.00. Revenue of $85.81M (+8.6% Y/Y) misses by $0.81M. Press
seekingalpha · 4天前
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2020
Reports Net Revenues of $85.8 Million for the Three Months Ended June 30, 2020RANCHO CUCAMONGA, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months
GlobeNewswire · 5天前
Amphastar Pharmaceuticals's Earnings: A Preview
On Thursday, August 06, Amphastar Pharmaceuticals (NASDAQ: AMPH) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.Earnings and Revenue Analysts expect Amphastar Pharmaceuticals earnings
Benzinga · 6天前
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020
RANCHO CUCAMONGA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its second quarter of 2020 ended June 30, 2020, after the market closes on Thursday, August 6th, 2020
GlobeNewswire · 07/30 20:05
Amphastar Pharmaceuticals (AMPH) Earnings Expected to Grow: Should You Buy?
Amphastar (AMPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/29 16:33
Are Robust Financials Driving The Recent Rally In Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock?
Simply Wall St. · 07/03 16:59
Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference
Amphastar Pharmaceuticals, Inc. (AMPH) announced today that Bill Peters, CFO, Dan Dischner, Vice President of Corporate Communications and Human Resources, and Tony Marrs, Sr. Vice President Regulatory Affairs and Clinical Operations will be presenting at BMO
GlobeNewswire · 06/19 10:05

所属板块

制药
-0.40%
制药与医学研究
-0.89%

热门股票

代码
价格
涨跌幅

AMPH 简况

Amphastar Pharmaceuticals, Inc.是一家专业制药公司。该公司主要专注于开发、制造、推广和销售仿制、注射和吸入产品。该公司通过两个部门运营:成品药部门和活性医药物成分(API)产品部门。成品药部门制造、推广及销售依诺肝素钠、Cortrosyn、Amphadase、纳洛酮、利多卡因,以及各种其他重症和非重症护理药物。API部门制造和销售重组人胰岛素和猪胰岛素。该公司生产和销售约20种产品。此外,该公司正在开发近10种仿制药简略新药申请(ANDA)、3种仿制生物和6种注射及吸入候选产品。
展开

微牛提供Amphastar Pharmaceuticals Inc(NASDAQ-AMPH)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的AMPH股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易AMPH股票基本功能。